|
Nonpneumatic Compression System or Garments (e.g., Dayspring)
|
Coverage
|
New |
02/19/2024 |
Investigative and therefore not covered
|
Nonpneumatic compression pumps or nonpneumatic sequential compression garments (e.g., Dayspring) are investigative for any indication.
Reliable evidence does not permit conclusions concerning its effectiveness.
|
|
Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM)
|
Coverage |
New |
01/15/2024 |
Covered for some indications; investigative and therefore not covered for all other indications |
Not investigative:
- RPM using an FDA approved device is not investigative for management of ANY of the following medical conditions in individuals cognitively and physically capable of operating the monitoring device and/or equipment:
- Chronic Obstructive Pulmonary Disease (COPD)
- Diabetes mellitus (see Medical Policy Continuous Glucose Monitoring (CGM) Systems)
- Heart failure
- Pregnant women with or at high risk of a hypertensive disorder
- when the technology in question meets ALL of the following:
- Prescribed by a treating specialist or subspecialist
- Physiologic data are electronically collected by the device and uploaded for analysis and interpretation
- Used for remote communication, counseling, and monitoring of acute or chronic health condition.
- Intended for the purpose of displaying or analyzing the physiological parameter(s) measured by the device
Investigative:
- Remote Patient Monitoring (RPM) is investigative for any other indications. Reliable evidence does not permit conclusions concerning its effectiveness.
- Remote Therapeutic Monitoring (RTM) is investigative for ALL indications. Reliable evidence does not permit conclusions concerning its effectiveness.
See the coverage policy and related documents for details.
|